04.09.2009 10:44 am
Psoriasis drug Raptiva being withdrawn from U.S. market
St. Louis Post-Dispatch
Genentech is removing its psoriasis drug Raptiva from the U.S. market through a phased withdrawal. The company said there’s a potential risk to patients of developing progressive multifocal leukoencephalopathy (PML), a rare, serious, progressive neurologic disease caused by a virus that affects the…
Loading ...- Comments Off
- Email this
